US 10493030
Combination HIV therapeutic
granted A61KA61K31/167A61K31/19
Quick answer
US patent 10493030 (Combination HIV therapeutic) held by Aphios Corporation expires Mon Nov 28 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Aphios Corporation
- Grant date
- Tue Dec 03 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 28 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 24
- CPC classes
- A61K, A61K31/167, A61K31/19, A61K31/20, A61K31/325